B3GAT1 and acute myeloid leukemia: In addition to decreased quantities of NK cells, Chretien et al. stated that AML subjects often have a less mature circulating NK cell phenotype, and they evaluated CD57 and KIR expression, which had inferior overall survival (OS) compared to AML subjects expressing a more mature NK cell profile both in the bone marrow and peripheral blood [30].